21 CFR 520.390b

§ 520.390b Chloramphenicol capsules.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.390b, § 520.390b Chloramphenicol capsules, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87102
Permanent ID: ys:prov:87102@1
SHA-256: 53cb16bcdde85e0acb98dd5a9274b8a57e45f6016055722713dcde02a11420d3

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each capsule contains 50, 100, 250, or 500 milligrams (mg) chloramphenicol. (b) Sponsors. See Nos. 050057 and 054771 in § 510.600(c) of this chapter for use as in paragraph (d) of this section. (c) Special considerations. Federal law prohibits the extralabel use of this product in food-producing animals. (d) Conditions of use in dogs—(1) Amount. 25 mg per pound of body weight every 6 hours. (2) Indications for use. For treatment of bacterial pulmonary infections, bacterial infections of the urinary tract, bacterial enteritis, and bacterial infections associated with canine distemper caused by susceptible organisms. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.